483 Roundup: FDA Hits Six Drugmakers for GMP Violations

Drug GMP Report
A A
The FDA cited six manufacturers for a variety of issues, including cross-contamination, complaint handling and quality system failures.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $200.00